Skip to content
PICO Portalanswers from OpenAlex

miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation

PaperCitations, authors & open-access status

miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation is a paper indexed in PICO Portal from OpenAlex.

How many citations does miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation have?

PICO Portalcitation count

miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation has 110 citations in the OpenAlex counts PICO Portal stores.

When was miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation published?

PICO Portalyear

miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation has 2016 year in the PICO Portal index.

What is the open-access status of miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation?

PICO Portaloa status

miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation has hybrid oa status in the PICO Portal index.

What is the DOI of miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation?

PICO Portaldoi

The DOI for miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation is on the source record.

What is the PMID of miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation?

PICO Portalpmid

The PMID for miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation is on the source record.

What is the OpenAlex record for miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation?

PICO Portalopenalex

The OpenAlex for miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial